HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Tetramer [Gly22-Thr302(HLA-E*01:03), Ile21-Met119(B2M) and VMAPRTLVL peptide] Accession # P13747(HLA-E*01:03)&P61769(B2M)&VMAPRTLVL | His | Avi |
N-term | C-term |
[8 Images]
规格 | 价 格(¥) | 数量 | |
¥14800 |
HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Monomer [Gly22-Thr302(HLA-E*01:03), Ile21-Met119(B2M) and VMAPRTLVL peptide] Accession # P13747(HLA-E*01:03)&P61769(B2M)&VMAPRTLVL | His | Avi |
N-term | C-term |
[4 Images]
规格 | 价 格(¥) | 数量 | |
¥4500 |
HLA-A*01:01&B2M&CT83 (NTDNNLAVY) Tetramer [Gly25-Thr305(HLA-A*01:01), Ile21-Met119(B2M) and NTDNNLAVY peptide] Accession # Q5SUL5(HLA-A*01:01)&P61769(B2M)&NTDNNLAVY | His | Avi |
N-term | C-term |
规格 | 价 格(¥) | 数量 | |
¥9900 |
HLA-A*01:01&B2M&CT83 (NTDNNLAVY) Monomer [Gly25-Thr305(HLA-A*01:01), Ile21-Met119(B2M) and NTDNNLAVY peptide] Accession # Q5SUL5(HLA-A*01:01)&P61769(B2M)&NTDNNLAVY | His | Avi |
N-term | C-term |
规格 | 价 格(¥) | 数量 | |
¥3000 |
HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Monomer [ Gly22-Thr302(HLA-E*01:03), Ile21-Met119(B2M) and VMAPRTLVL peptide] Accession # P13747(HLA-E*01:03)&P61769(B2M)&VMAPRTLVL | His | Avi |
N-term | C-term |
[6 Images]
规格 | 价 格(¥) | 数量 | |
¥3000 |
HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Tetramer [Gly22-Thr302(HLA-E*01:03), Ile21-Met119(B2M) and VMAPRTLVL peptide] Accession # P13747(HLA-E*01:03)&P61769(B2M)&VMAPRTLVL | His | Avi |
N-term | C-term |
[10 Images]
规格 | 价 格(¥) | 数量 | |
¥9900 |
HLA-G&B2M&Peptide (RIIPRHLQL) Monomer[ Gly25-Thr305 (HLA-G), Ile21-Met119 (B2M) and RIIPRHLQL peptide] Accession # O02948(HLA-G)&Q6V7J5(B2M)&RIIPRHLQL | His | Avi |
N-term | C-term |
[8 Images]
规格 | 价 格(¥) | 数量 | |
¥3000 |
HLA-G&B2M&Peptide (RIIPRHLQL) Tetramer [Gly25-Thr305(HLA-G), Ile21-Met119(B2M) and RIIPRHLQL peptide] Accession # E0WKX9(HLA-G)&Q8SPW0(B2M)&RIIPRHLQL | His | Avi |
N-term | C-term |
规格 | 价 格(¥) | 数量 | |
¥9900 |
MICA (Glu1-Trp284) Accession # AAO24115.1 | His |
N-term | C-term |
规格 | 价 格(¥) | 数量 | |
¥3500 |
规格 | 价 格(¥) | 数量 | |
¥300 |